Protocol GELLC-7: Ibrutinib Followed by Ibrutinib Consolidation in Combination With Ofatumumab

Clinical trial NCT03280160 · UNKNOWN

Trial details

NCT number: NCT03280160
Sponsor: PETHEMA Foundation
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Lymphocytic Leukemia

Start date: 2017-09-07
Primary completion: 2018-07-13
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.